PYXIS INNOVATIONS INC 4
4 · INTERLEUKIN GENETICS INC · Filed Dec 19, 2007
Insider Transaction Report
Form 4
PYXIS INNOVATIONS INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2007-12-17Exercise: $0.64→ Common Stock (3,190,988 underlying) - Conversion
Common Stock
2007-12-17$0.64/sh+3,190,988$2,039,680→ 5,941,025 total
Footnotes (2)
- [F1]Pyxis held convertible promissory notes issued by the Issuer with an aggregate original principal amount of $2,000,000 which it elected to convert on December 17, 2007. The original principal amount of the convertible promissory notes, plus accrued interest thereon, was convertible into common stock at any time at a conversion price equal to two times the conversion price of the Issuer's Series A Preferred Stock in effect at the time of the conversion and the note was convertible at any time at the option of Pyxis.
- [F2]Pyxis holds a convertible promissory note issued by the Issuer with an original principal amount of $595,336. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. This promissory note will be convertible into shares of common stock at a conversion price equal to two times the conversion price of the Issuer's Series A Preferred Stock in effect at the time of conversion. As of September 30, 2007, the convertible promissory note would have been convertible into 861,842 shares of the Issuer's common stock.